Text Size

Study of the Relationship Between Serum Adiponectin and Clinical Prognosis in Patients Undergoing Cardiac Surgery

This study is not yet open for participant recruitment.
Verified July 2011 by Xijing Hospital
Sponsor:
Information provided by:
Xijing Hospital
ClinicalTrials.gov Identifier:
NCT01393535
First received: July 11, 2011
Last updated: NA
Last verified: July 2011
History: No changes posted
  Purpose

The purpose of this study is to investigate the relationship between serum adiponectin and clinical prognosis in patients undergoing cardiac surgery.


Condition
Cardiac Surgery

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Study of the Relationship Between Serum Adiponectin and Clinical Prognosis in Patients Undergoing Cardiac Surgery

Resource links provided by NLM:

MedlinePlus related topics: Heart Surgery
U.S. FDA Resources

Further study details as provided by Xijing Hospital:

Estimated Enrollment: 800
Study Start Date: July 2011
Estimated Study Completion Date: August 2012
Estimated Primary Completion Date: July 2012 (Final data collection date for primary outcome measure)
Detailed Description:

Adiponectin, an adipose tissue derived protein, is an abundant protein hormone regulatory of numerous metabolic processes. Since its discovery, adiponectin has garnered considerable attention for its role in cardiovascular pathology. It has been shown to be a predictor of cardiovascular events in both the general population and patients undergoing cardiac surgery. In this study,we are planning to investigate the relationship between serum adiponectin and clinical prognosis in patients undergoing cardiac surgery.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Patients underwent cardiac surgery in cardiovascular surgery department of xijing hospital.

Criteria

Inclusion Criteria:

  • Patients who had underwent cardiac surgery from July 2011 to August 2012 in xijing hospital.

Exclusion Criteria:

  • Nothing particular.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01393535

Contacts
Contact: Chunhu Gu, MD guchunhu@fmmu.edu.cn

Locations
China, Shannxi
Xijing Hospital Not yet recruiting
Xi'an, Shannxi, China, 710032
Contact: Chunhu Gu, MD         guchunhu@fmmu.edu.cn    
Principal Investigator: Chunhu Gu, MD            
Principal Investigator: Yukun Cao, MD            
Sponsors and Collaborators
Xijing Hospital
Investigators
Study Chair: Dinghua Yi, MD Xijing Hospital
  More Information

No publications provided

Responsible Party: Chunhu Gu, Xijing Hospital
ClinicalTrials.gov Identifier: NCT01393535     History of Changes
Other Study ID Numbers: Guch-013
Study First Received: July 11, 2011
Last Updated: July 11, 2011
Health Authority: China: Food and Drug Administration

Keywords provided by Xijing Hospital:
Adiponectin
Prognosis
Cardiac Surgery

ClinicalTrials.gov processed this record on May 22, 2013